27.04.2017 22:06:09

Vertex Pharmaceuticals Inc. Q1 Profit Advances 352%

(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) released earnings for its first quarter that increased from last year.

The company said its bottom line rose to $101.41 million, or $0.41 per share. This was up from $22.42 million, or $0.09 per share, in last year's first quarter.

Analysts had expected the company to earn $0.4 per share, according figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.

The company said revenue for the quarter rose 79.5% to $714.72 million. This was up from $398.08 million last year.

Vertex Pharmaceuticals Inc. earnings at a glance:

-Earnings (Q1): $101.41 Mln. vs. $22.42 Mln. last year. -Earnings Growth (Y-o-Y): 352.3% -EPS (Q1): $0.41 vs. $0.09 last year. -EPS Growth (Y-o-Y): 355.6% -Analysts Estimate: $0.4 -Revenue (Q1): $714.72 Mln vs. $398.08 Mln last year. -Revenue Change (Y-o-Y): 79.5%

Analysen zu Vertex Pharmaceuticals Inc.mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Vertex Pharmaceuticals Inc. 461,35 2,90% Vertex Pharmaceuticals Inc.